All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - Discussion.

3 September 2019 (12:15 - 12:30)
Organised by:
Congress Presentation Part of: Controversies in antithrombotic treatment for primary and secondary prevention Cardiovascular Pharmacotherapy ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by